Ex parte FITZPATRICK et al. - Page 5




          Appeal No. 94-3823                                                          
          Application 07/812,249                                                      



               The examiner rejected claims 1-15, under 35 U.S.C. § 112,              
          first paragraph, as corresponding to a specification that lacks             
          an enabling disclosure.  In particular, the examiner states:                
               An integral part of applicant's invention is the                       
               use of probabilities [in figures 2 and 3] to select                    
               a recognized character.  How are these probabilities                   
               calculated (especially in regard to the color coded                    
               characters)?  This is a necessary part of the                          
               invention, and has not been addressed in the                           
               applicant's specification.                                             
          Answer at 4.                                                                
               Appellants argue that such calculation of probabilities is             
          conventional and would be known to those with ordinary skill in             
          the art, as evidenced by Highleyman.  Brief at 4.   We agree.               
               The test for enablement under 35 U.S.C. § 112, first                   
          paragraph, is whether one reasonably skilled in the art could               
          make or use the claimed invention from the disclosed subject                
          matter together with information in the art without undue                   
          experimentation.  United States v. Telectronics, Inc., 857 F.2d             
          778, 785, 8 USPQ2d 1217, 1223 (Fed. Cir. 1988), cert. denied,               
          490 U.S. 1046 (1989).  A disclosure can be enabling even though             
          some experimentation is necessary.  Hybritech Inc. v. Monoclonal            
          Antibodies, Inc., 802 F.2d 1367, 1384, 231 USPQ 81, 94 (Fed. Cir.           
          1986), cert. denied, 480 U.S. 947 (1987).  The issue is whether             


                                          5                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007